Glioblastoma multiforme (GBM), the most common and aggressive primary brain tumor, has
a high mortality rate despite extensive efforts to develop new treatments. GBM exhibits both …

Abstract Learning Objectives After completing this course, the reader will be able to:
Differentiate between the actions of oncogenes and tumor suppressor genes in the …

Human cytomegalovirus (HCMV), a member of the herpesvirus family, is a large complex
enveloped virus composed of both viral and cellular gene products. While the sequence of …

The leading figure in qualitative health research (QHR), Janice M. Morse, asserts that QHR
is its own separate discipline—distinct from both traditional health research and other kinds …

Over the past years, it has become evident that cancer initiation and progression depends
on several components of the tumor microenvironment, including inflammatory and immune …

Recent advances in proteomics technologies provide tremendous opportunities for
biomarker-related clinical applications; however, the distinctive characteristics of human …

Clinical cancer proteomics aims at the identification of markers for early detection and
predictive purposes, as well as to provide novel targets for drug discovery and therapeutic …

The proteins secreted by various cells (the secretomes) are a potential rich source of
biomarkers as they reflect various states of the cells at real time and at given conditions. To …

Cancer is a leading cause of death. Early detection is usually associated with better clinical
outcomes. Recent advances in genomics and proteomics raised hopes that new biomarkers …

Concerns about the potential adverse health effects of engineered nanoparticles stems in
part from the possibility that some materials display unique chemical and physical properties …